Screener Summaries Updates Institutions Sign In More Updates › Earnings › ELV Earnings · Nov 10, 2025
Elevance Health expects to reaffirm its full-year 2025 guidance during upcoming investor meetings, including… ELV Elevance Health, Inc.
Elevance Health expects to reaffirm its full-year 2025 guidance during upcoming investor meetings, including shareholders' earnings of approximately $24.70 per diluted share. This includes approximately $5.30 of net unfavorable items, resulting in adjusted earnings of approximately $30.00 per diluted share and a benefit expense ratio of approximately 90.0%.
More from Elevance Health, Inc. Elevance Health raises full-year adjusted diluted EPS guidance to at least $29.00 on operating momentum Oct 21, 2026 Elevance Health reaffirms full-year 2026 earnings guidance of at least $27.00 adjusted per diluted share Sep 10, 2026 Elevance Health, Inc. issued a press release on July 15, 2026, reporting its financial results for the quarter ended… Jul 15, 2026 Elevance Health, Inc. reaffirmed its full year 2026 shareholders' earnings guidance of at least $19.85 per diluted… Jun 10, 2026 Elevance Health, Inc. held its annual meeting of shareholders on May 13, 2026, resulting in the election of three… May 13, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
